Home-use faecal immunochemical testing: primary care diagnostic technology update
Open Access
- 2 March 2015
- journal article
- review article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 65 (632) , 156-158
Abstract
#### Clinical Question What is the evidence base for home faecal immunochemical testing for colorectal cancer? A variety of home-use faecal occult blood testing (FOBt) kits remain commercially available to UK patients despite caution regarding their safety and accuracy. FOBt is a relatively non-invasive and inexpensive test. The NHS Bowel Cancer Screening Programme (BCSP) and the majority of European screening programmes uses guaiac FOBt (gFOB). A Cochrane Review has shown that biennial population screening with card-based postal laboratory-analysed gFOB can reduce colorectal mortality by 15% (relative risk [RR] 0.85, confidence interval [CI] = 0.78 to 0.92) in people aged 45–74 years.1 Those who attend screening have a 25% reduction (RR 0.75, CI = 0.66 to 0.84) in their risk of death, but only 40% return all three BCSP gFOB kits, although involving GPs in screening increases uptake.1,2 Faecal immunochemical testing (FIT) measures the globin component of human haemoglobin. Unlike gFOB, FIT does not require dietary restriction, is specific to lower gastrointestinal (GI) cancers as upper GI enzymes degrade human globin, and is less affected by concomitant medication use. FIT has started to replace gFOB in some regions (for example, the Czech Republic and Italy) and guidelines (for example, the US) given these gains in diagnostic accuracy. Home FIT kits are designed to obtain samples from multiple parts of a single stool and use immunochromatography to provide an immediate (qualitative) positive or negative result, avoiding the delay and costs associated with laboratory (quantitative) FIT and gFOB. Patients may present to primary care having used home bowel-testing kits, and so this report outlines the existing evidence detailing the potential accuracy and utility of the home FIT available to the adult consumer. Based on a search conducted in December 2013, Box 1 shows the CE approved FIT kits retailing to the UK …Keywords
This publication has 11 references indexed in Scilit:
- Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programmeGut, 2014
- Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)Gut and Liver, 2014
- Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screeningEuropean Journal Of Cancer Prevention, 2013
- Immunological faecal occult blood testing: A discriminatory test to identify colorectal cancer in symptomatic patientsInternational Journal of Surgery, 2013
- Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007Acta Oncologica, 2013
- Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancerEuropean Journal of Cancer, 2012
- Comparing participation rates between immunochemical and guaiac faecal occult blood tests: A systematic review and meta-analysisPreventive Medicine, 2012
- Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysisBMJ, 2010
- Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopyGut, 2009
- Screening for colorectal cancer using the faecal occult blood test, HemoccultCochrane Database of Systematic Reviews, 2007